4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-017038
Chief Tech. Operations Officer sold 1,500 shares at an average $36.13 ($54,202)
- Chief Tech. Operations Officer acquired 1,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newell Joe Chief Tech. Operations Officer | 2019-03-01 | Option exercise | +1,500 | $20.40 | $30,600 | 48,646 | D |
| Newell Joe Chief Tech. Operations Officer | 2019-03-01 | Sale | −1,300 | $36.04 | $46,852 | 47,346 | D |
| Newell Joe Chief Tech. Operations Officer | 2019-03-01 | Sale | −200 | $36.75 | $7,350 | 47,146 | D |
| Derivatives | |||||||
| Newell Joe Chief Tech. Operations Officer | 2019-03-01 | Option exercise · Employee Stock Option (Right to Buy) | −1,500 | 68,000 | D | ||
| Open-market sales · 1,500 sh · avg $36.13 · $54,202 | |||||||
Loading xslF345X03/doc4.xml…